Status:
COMPLETED
Advanced MRI Scan Before and After Radiation Therapy for the Detection of Intracranial Metastasis
Lead Sponsor:
M.D. Anderson Cancer Center
Collaborating Sponsors:
National Cancer Institute (NCI)
Conditions:
Malignant Solid Neoplasm
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
This clinical trial studies the different types of investigational imaging techniques called sequences during magnetic resonance imaging (MRI) of the head before and after radiation therapy in patient...
Detailed Description
PRIMARY OBJECTIVES: I. Conspicuity: Ia. To assess the conspicuity of idealized T1 and T2 imaging at detecting brain metastases at baseline. (Quantitative MRI) Ib. To assess the conspicuity (CNR) of ...
Eligibility Criteria
Inclusion
- An adult patient with pathology-proven solid organ cancer
- MRI of the brain with contrast, positive for at least one intra-axial metastatic lesion greater than 5 mm
- Planned treatment with stereotactic radiation
Exclusion
- Contraindication to MR imaging
- Known allergy to gadolinium-based contrast agents
- Renal failure as defined by a glomerular filtration rate (GFR) less than 30 or the use of hemodialysis
- Pregnant
- Patients less than 18 years of age will be excluded
Key Trial Info
Start Date :
March 30 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 29 2023
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT04870645
Start Date
March 30 2021
End Date
August 29 2023
Last Update
November 6 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
M D Anderson Cancer Center
Houston, Texas, United States, 77030